Drugs / Polyunsaturated Fatty Acids
Polyunsaturated Fatty Acids
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT00380926 | Apr → Nov 2004 | allergic asthma | Johann Wolfgang Goethe University Hospital | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00067301 | Sep 2003 → Apr 2007 | major depressive disorder | National Center for Complementary and Integrative Health (NCCIH) | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT06254118 | Jan 2020 → Jan 2022 | chronic periodontitis | Hadir F. El-Dessouky | Completed | No outcome recorded |
Press releases naming this drug 2 releases
| Date | Issuer | Release |
|---|---|---|
| 2014-10-27 | Otsuka Pharmaceutical Development & Commercialization, Inc. | New product for Japanese women Nature Made Fish Oil Pearl Small Pearl-shaped Capsules Concentrated With Essential Nutritional Balance of Fish Oil otsuka.co.jp ↗ |
| 2010-11-14 | GlaxoSmithKline | New study findings show no benefit of prescription omega-3 fatty acids in prevention of recurrent symptomatic atrial fibrillation in affected patients gsk.com ↗ |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Polyunsaturated Fatty Acids | “We investigated the anti-inflammatory potential of polyunsaturated fatty acids (PUFA) in allergic asthma.” NCT00380926 ↗ |
| Known as | fish oil | “Native populations consuming high amounts of fish suffer less from allergic diseases. The purpose of this study is to determine whether polyunsaturated fatty acids (fish oil)...” NCT00380926 ↗ |
| Known as | n-3PUFAs | “One potential treatment for MDD is n-3 polyunsaturated fatty acids (n-3PUFAs), also known as omega-3 oils, naturally found in fatty fish, some other seafood, and some nuts and seeds.” PMID 34817851 ↗ Nov 2021 |
| Known as | omega-3 fatty acids | “OBJECTIVES: To assess the effects of n-3 polyunsaturated fatty acids (also known as omega-3 fatty acids) versus a comparator (e.g. placebo, antidepressant treatment, standard...” PMID 34817851 ↗ Nov 20211“omega-3 fatty acids” NCT06254118 ↗ |
| Known as | omega-3 oils | “One potential treatment for MDD is n-3 polyunsaturated fatty acids (n-3PUFAs), also known as omega-3 oils, naturally found in fatty fish, some other seafood, and some nuts and seeds.” PMID 34817851 ↗ Nov 2021 |
| Modality | Other / unclassified | “dietary supplementation with a PUFA enriched fat blend” NCT00380926 ↗ |
| Route | Oral | “patients treated by scaling and root planing and oral systemic administration of Omega-3 fatty acids” NCT06254118 ↗ |